1. Home
  2. ADMA vs GLBE Comparison

ADMA vs GLBE Comparison

Compare ADMA & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • GLBE
  • Stock Information
  • Founded
  • ADMA 2004
  • GLBE 2013
  • Country
  • ADMA United States
  • GLBE Israel
  • Employees
  • ADMA N/A
  • GLBE N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • GLBE Computer Software: Prepackaged Software
  • Sector
  • ADMA Health Care
  • GLBE Technology
  • Exchange
  • ADMA Nasdaq
  • GLBE Nasdaq
  • Market Cap
  • ADMA 5.1B
  • GLBE 6.1B
  • IPO Year
  • ADMA N/A
  • GLBE 2021
  • Fundamental
  • Price
  • ADMA $17.74
  • GLBE $31.31
  • Analyst Decision
  • ADMA Strong Buy
  • GLBE Strong Buy
  • Analyst Count
  • ADMA 4
  • GLBE 14
  • Target Price
  • ADMA $24.25
  • GLBE $49.00
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • GLBE 2.3M
  • Earning Date
  • ADMA 08-07-2025
  • GLBE 08-13-2025
  • Dividend Yield
  • ADMA N/A
  • GLBE N/A
  • EPS Growth
  • ADMA N/A
  • GLBE N/A
  • EPS
  • ADMA 0.84
  • GLBE N/A
  • Revenue
  • ADMA $459,381,000.00
  • GLBE $796,773,000.00
  • Revenue This Year
  • ADMA $23.35
  • GLBE $27.03
  • Revenue Next Year
  • ADMA $27.67
  • GLBE $24.56
  • P/E Ratio
  • ADMA $21.27
  • GLBE N/A
  • Revenue Growth
  • ADMA 62.23
  • GLBE 33.20
  • 52 Week Low
  • ADMA $10.21
  • GLBE $26.64
  • 52 Week High
  • ADMA $25.67
  • GLBE $63.69
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 32.83
  • GLBE 39.03
  • Support Level
  • ADMA $20.42
  • GLBE $30.98
  • Resistance Level
  • ADMA $22.37
  • GLBE $34.66
  • Average True Range (ATR)
  • ADMA 0.88
  • GLBE 1.11
  • MACD
  • ADMA -0.28
  • GLBE -0.13
  • Stochastic Oscillator
  • ADMA 1.07
  • GLBE 20.08

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

Share on Social Networks: